Showing results (411-420 of 2,639) with videos related to

Sort By:
Pageof 264
Hematology (Amsterdam, Netherlands)|September 29, 2005
Treatment of T-Cell lymphomaTomomitsu Hotta
Hematology (Amsterdam, Netherlands)|September 29, 2005
Clinical, pathological and molecular features of the chronic myeloproliferative disorders: MPD 2005 and beyondJan Jacques Michiels
Hematology (Amsterdam, Netherlands)|September 29, 2005
The myelodysplastic syndromes: diagnosis, molecular biology and risk assessmentJohn M Bennett, Rami S Komrokji
Hematology (Amsterdam, Netherlands)|June 19, 2010
The expression of LMO2 protein in acute B-cell and myeloid leukemiaUmit Cobanoglu, Mehmet Sonmez, Hasan Mucahit Ozbas, et al.
Hematology (Amsterdam, Netherlands)|June 19, 2010
Are serum nitric oxide and vascular endothelial growth factor levels affected by packed red blood cell transfusions?Ebru Ergenekon, Davut Bozkaya, Tayfun Goktas, et al.
Hematology (Amsterdam, Netherlands)|July 31, 2010
Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patientsC S Chim, J P Sim, C C Chan, et al.
Hematology (Amsterdam, Netherlands)|July 31, 2010
Early infections in patients undergoing high-dose treatment with stem cell support: a comparison of patients with non-Hodgkin lymphoma and multiple myelomaA O Gang, M Arpi, Uffe J O Gang, et al.
Hematology (Amsterdam, Netherlands)|July 31, 2010
Gene expression profiling of CD3gamma, delta, epsilon, and zeta chains in CD4(+) and CD8(+) T cells from human umbilical cord bloodShaohua Chen, Lijian Yang, Xiaoye Lu, et al.
Hematology (Amsterdam, Netherlands)|September 14, 2007
Protein phosphatase 2A (PP2A) has a potential role in CAPE-induced apoptosis of CCRF-CEM cells via effecting human telomerase reverse transcriptase activityCigir Biray Avci, Fahri Sahin, Cumhur Gunduz, et al.
Hematology (Amsterdam, Netherlands)|September 14, 2007
Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseasesKaterina Panteli, Maria Bai, Eleftheria Hatzimichael, et al.
Pageof 264